New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
16:22 EDTULTA, GMCR, ARO, SIRI, CELG, SBUX, LMCAOn The Fly: Closing Wrap
Stocks on Wall Street were lower following another session dominated by headlines concerning the geopolitical situation. Stocks were lower early in the session following the lower than expected University of Michigan consumer confidence reading. The market moved in a narrow range and crossed back and forth across the flat-line several times. Investors remain on edge following several recent poor economic reports out of China and frequent remainders of the upcoming elections in the Ukraine on Sunday. ECONOMIC EVENTS: In the U.S., producer prices fell 0.1% overall in February, versus an expected increase of 0.2%. The core reading, which excludes food and energy, fell 0.2%, versus an expected increase of 0.1%. The Reuters/University of Michigan Consumer Sentiment Survey for March unexpectedly dropped to a four-month low of 79.9. The preliminary reading for the month was expected by analysts to have come in at 81.8, which would have been a slight bump from the prior 81.6 figure. In Europe, citizens of the Crimea region of the Ukraine are likely to vote to secede this weekend, even as Ukraine, the U.S and the European Union maintain that the vote is illegal. U.S. Secretary of State John Kerry said he was told that Vladimir Putin is not prepared to make any decision regarding Ukraine until after the country's referendum. COMPANY NEWS: Liberty Media (LMCA) shares gained $9.11, or 7.22%, to $135.25 after the company announced last night that it plans to reclassify its common stock into two tracking stocks, one called Liberty Media Group and the other called Liberty Broadband Group. Liberty President & CEO Greg Maffei called the move "another step in Liberty’s process of offering investors greater choice, transparency and focus." Liberty said in conjunction with the plan that it would drop plans to buy the rest of Sirius XM (SIRI), in which it currently holds a 53% stake in. Sirius XM had previously suspended its stock repurchase program in connection with Liberty Media's proposal and it announced today that it now intends to resume the repurchase plan. Shares of Sirius advanced 7c, or 2.08%, to $3.44 following the news. MAJOR MOVERS: Among the notable gainers was beauty retailer Ulta Salon (ULTA), which advanced $5.75, or 6.42%, to $95.26 after the company’s fourth quarter results beat estimates. Also higher were shares of single-serve coffee machine maker Keurig Green Mountain (GMCR), which rose $7.09, or 6.68%, to $113.25 after the company agreed to new terms in its deal with coffee giant Starbucks (SBUX). Among the noteworthy losers was teen retailer Aeropostale (ARO), which dropped $1.47, or 20.14%, to $5.83 after its fourth quarter results and first quarter outlook missed analysts' consensus expectations and the company entered a financing deal with private equity firm Sycamore Partners. Also lower were shares of drug maker Celgene (CELG), which dropped $6.59, or 4.22%, to $149.41 after the U.K.'s healthcare guidance body issued new draft guidance on the use of the company's Revlimid drug. INDEXES: The Dow fell 43.22, or 0.27%, to 16,065.67, the Nasdaq dropped 15.02, or 0.35%, to 4,245.40, and the S&P 500 declined 5.21, or 0.28%, to 1,841.13.
News For LMCA;SIRI;GMCR;SBUX;ARO;ULTA;CELG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
January 27, 2016
10:36 EDTGMCROptions with increasing implied volatility: SNDK GMCR
January 26, 2016
10:48 EDTGMCR, SBUXTreeHouse may benefit from strategy shifts, says Detwiler Fenton
Detwiler Fenton said TreeHouse (THS) may benefit from Keurig Green Mountain's (GMCR) and Starbucks' (SBUX) focust shift into new products. Keurig Green Mountain dropping of its private-label business opens the door for TreeHouse to take market share, the firm's analyst said. Detwiler sees TreeHouse benefiting from Starbucks' shifts away from Keurig Green Mountain and into other product opportunities.
10:32 EDTGMCROptions with increasing implied volatility: CLDX SNDK GMCR RAD
Subscribe for More Information
January 25, 2016
11:05 EDTCELGOncoMed price target lowered to $29 from $43 at Piper Jaffray
Subscribe for More Information
10:57 EDTCELGCelgene management to meet with Evercore ISI
Meeting to be held in Canada on February 1 hosted by Evercore ISI.
09:32 EDTSBUXApple Active equity options trading on open
Subscribe for More Information
05:36 EDTCELGStocks with implied volatility below IV index mean; CELG INTC
Subscribe for More Information
January 22, 2016
15:35 EDTCELGCelgene presents analyses of Abraxane studies
Subscribe for More Information
11:49 EDTSBUXOptions with increasing put volume
Subscribe for More Information
10:01 EDTSBUXStarbucks off lows after CEO calls stock undervalued
Shares of Starbucks are off their lows after its CEO Howard Schultz called the stock undervalued. While speaking on CNBC, Schultz said he will "back up the truck" at current levels when answering a question from Jim Cramer about share buybacks. He also called the notion that the company lowered its China forecast "ridiculous." Schultz said his company's business in China "has never been stronger." Starbucks is down 75c to $58.28 in morning trading. The stock touched $57.41 today. Starbucks reported earnings results last night for its fiscal first quarter.
09:54 EDTSBUXStarbucks CEO says stock undervalued, 'will back truck up' at these levels
Howard Schultz is speaking on CNBC.
09:52 EDTSBUXStarbucks CEO says notion that forecast was lowered is 'ridiculous'
Subscribe for More Information
09:47 EDTSBUXStarbucks CEO says business in China 'has never been stronger'
Howard Schultz is speaking on CNBC.
09:34 EDTSBUXActive equity options trading on open
Subscribe for More Information
09:28 EDTSBUXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: 8x8, Inc. (EGHT), up 12.5%... Intuitive Surgical (ISRG), up 2.2%. ALSO HIGHER: Apple (AAPL), up 1.9% after Piper Jaffray's Gene Munster says that Apple could rally over 50% by September... Chesapeake Energy (CHK), up 6.4% after announcing that it is suspending its quarterly preferred stock dividends... NephroGenex (NRX), up 27.3% after the independent Data and Safety Monitoring Board recommendation to continue the Pyridorin study... Avon Products (AVP), up 4.4% after being upgraded to Overweight from Neutral at Piper Jaffray... Freeport-McMoRan (FCX), up 6.7% after Reuters reports that Indonesia asked the company to set aside another $530M into an escrow account for the miner to extend its permit to export copper concentrate. DOWN AFTER EARNINGS: American Express (AXP), down 6.9%... Starbucks (SBUX), down 2.6%... Cardiovascular Systems (CSII), down 32.3%... GE (GE), down marginally. ALSO LOWER: Barrick Gold (ABX), down 3.4% after giving fourth quarter and fiscal 2015 production guidance and announcing potential asset impairment charges of $1B-$1.2B.
09:04 EDTSBUXStarbucks weakness creates buying opportunity, says BMO Capital
Subscribe for More Information
08:02 EDTSBUXStarbucks reported strong Q1 results, says Wells Fargo
Afrter Starbucks reported higher than expected Q1 EPS, Wells Fargo says that the company's 8% global SSS sales growth was "impressive." The firm says that the company is successfully executing on many initiatives, especially food. The firm thinks the company is poised to deliver strong results going forward, given its innovations and "vast international opportunity." Wells recommends buying the shares on any pullbacks and keeps an Outperform rating on the stock.
07:31 EDTCELGCelgene says 10 ABRAXANE studies presented at 2016 ASCO GI
Celgene announced that 10 studies highlighting combinations that include a foundation of ABRAXANE and gemcitabine are being presented during the 2016 ASCO Gastrointestinal Cancers Symposium, establishing the therapy as the foundation for research in first-line metastatic pancreatic cancer. "ABRAXANE is the only chemotherapy approved in combination with gemcitabine based on an improvement in overall survival for first line metastatic pancreatic cancer patients and is fast becoming the standard of care in this extremely difficult to treat disease," said Jacqualyn A. Fouse, Ph.D., President, Hematology/Oncology for Celgene. "We are excited that ABRAXANE plus gemcitabine is serving as the foundation for a new wave of potential treatments that may further improve the treatment paradigm in this disease and are fully committed to continuing to serve these patients."
07:25 EDTSBUXStarbucks should be bought on the weakness, says Deutsche Bank
Deutsche Bank analyst Karen Short recommends using the post-earnings pullback in shares of Starbucks as a buying opportunity. The selloff is related to more modest international same-store-sales and lower than consensus Q2 guidance, but expectations were very high, Short tells investors in a post-earnings research note. Starbucks continues to generate best-in-class same-store-sales across the Americas, the analyst contends. She reiterates a Buy rating on the stock with a $70 price target. Shares of the coffee giant are down $1.79 to $57.24 in pre-market trading.
06:40 EDTSBUXPiper reiterates Starbucks as top pick for the year
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use